Literature DB >> 22494332

Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses).

Timothy R Deer1, Joshua Prager, Robert Levy, James Rathmell, Eric Buchser, Allen Burton, David Caraway, Michael Cousins, José De Andrés, Sudhir Diwan, Michael Erdek, Eric Grigsby, Marc Huntoon, Marilyn S Jacobs, Philip Kim, Krishna Kumar, Michael Leong, Liong Liem, Gladstone C McDowell, Sunil Panchal, Richard Rauck, Michael Saulino, B Todd Sitzman, Peter Staats, Michael Stanton-Hicks, Lisa Stearns, Mark Wallace, K Dean Willis, William Witt, Tony Yaksh, Nagy Mekhail.   

Abstract

INTRODUCTION: Continuous intrathecal infusion of drugs to treat chronic pain and spasticity has become a standard part of the algorithm of care. The use of opioids has been associated with noninfectious inflammatory masses at the tip of the intrathecal catheter, which can result in neurologic complications.
METHODS: The Polyanalgesic Consensus Conference is a meeting of a group of well-published and experienced practitioners; the purpose of the meeting is to update the standard of care for intrathecal therapies to reflect current knowledge gleaned from literature and clinical experience. An exhaustive literature search was performed, and information from this search was provided to panel members. Analysis of the published literature was coupled with the clinical experience of panel participants to form recommendations regarding intrathecal inflammatory masses or granulomas.
RESULTS: The panel has made recommendations for the prevention, diagnosis, and management of intrathecal granulomas.
CONCLUSION: The use of chronic infusions of intrathecal opioids is associated with the formation of inflammatory masses at the intrathecal catheter tip in a small minority of treated patients. Nonetheless, the appearance of these space-occupying lesions can lead to devastating neurologic sequelae. The prevention, early detection, and successful treatment of intraspinal granulomas are important considerations when offering intrathecal drug therapy to patients with chronic intractable pain.
© 2012 International Neuromodulation Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22494332     DOI: 10.1111/j.1525-1403.2012.00449.x

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  13 in total

Review 1.  Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.

Authors:  Catherine Smyth; Nadera Ahmadzai; Jason Wentzell; Ashley Pardoe; Andrew Tse; Tiffany Nguyen; Yvette Goddard; Shona Nair; Patricia A Poulin; Becky Skidmore; Mohammed T Ansari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

Review 2.  Intrathecal therapy for chronic pain: current trends and future needs.

Authors:  Salim M Hayek; Michael C Hanes
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 3.  Considerations for evaluating the use of intrathecal drug delivery in the oncologic patient.

Authors:  Amitabh Gulati; Vinay Puttanniah; Joseph Hung; Vivek Malhotra
Journal:  Curr Pain Headache Rep       Date:  2014-02

Review 4.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

5.  Role of meningeal mast cells in intrathecal morphine-evoked granuloma formation.

Authors:  Tony L Yaksh; Jeffery W Allen; Samantha L Veesart; Kjersti A Horais; Shelle A Malkmus; Miriam Scadeng; Joanne J Steinauer; Steve S Rossi
Journal:  Anesthesiology       Date:  2013-03       Impact factor: 7.892

6.  Characterization of Effect of Repeated Bolus or Continuous Intrathecal Infusion of Morphine on Spinal Mass Formation in the Dog.

Authors:  Keith R Hildebrand; Linda M Page; Tina M Billstrom; Joanne J Steinauer; Kelly A Eddinger; Shervin Arjomand; Tony L Yaksh
Journal:  Neuromodulation       Date:  2019-05-23

Review 7.  Role of Catheter's Position for Final Results in Intrathecal Drug Delivery. Analysis Based on CSF Dynamics and Specific Drugs Profiles.

Authors:  De Andres Jose; Perotti Luciano; Villanueva Vicente; Asensio Samper Juan Marcos; Fabregat-Cid Gustavo
Journal:  Korean J Pain       Date:  2013-10-02

Review 8.  Current perspectives on intrathecal drug delivery.

Authors:  Michael M Bottros; Paul J Christo
Journal:  J Pain Res       Date:  2014-11-06       Impact factor: 3.133

Review 9.  Programmable intrathecal pumps for the management of chronic pain: recommendations for improved efficiency.

Authors:  Denise Wilkes
Journal:  J Pain Res       Date:  2014-10-03       Impact factor: 3.133

10.  Alfentanil: correlations between absence of effect upon subcutaneous mast cells and absence of granuloma formation after intrathecal infusion in the dog.

Authors:  Tony L Yaksh; Joanne J Steinauer; Samantha L Veesart; Shelle A Malkmus
Journal:  Neuromodulation       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.